IDH2 and oligodendroglioma: Within the adult-type diffuse glioma classification, the significance of a neoplasm harboring an IDH mutation evolved from the WHO 2016 classification, now denoting either an IDH-mutant astrocytoma or IDH-mutant oligodendroglioma, dependent on the 1p19q status.